ArticleJournal of imaging informatics in medicine2026
Glioma Segmentation on Multicenter 2D-Based Magnetic Resonance Imaging Using Low-Rank Adaptation Tuning of a Foundation Model: An External Test Evaluation.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Research on foundation models is actively progressing. The segment anything model (SAM) and MedSAM are representative foundation models for image segmentation. Recently, low-rank adaptation (LoRA) has been developed, allowing parameter updates without retraining the entire model, thus solving the problem with large data and time required for task-specific fine-tuning. Although many studies have used public databases, few have focused on local data. Moreover, to our knowledge, no studies have fine-tuned MedSAM using LoRA. We aimed to evaluate SAM, MedSAM, and their LoRA-tuned variants (SAM-LoRA and MedSAM-LoRA) using brain magnetic resonance images of gliomas from five centers in Japan and to compare their performance. We used 2D-based fluid-attenuated inversion recovery axial images and conducted parameter optimization based on four-fold cross-validation (189 cases) and external test evaluation (75 cases) using cases collected retrospectively. Dice coefficients, intersection over union (IoU), and the 95% Hausdorff distance (HD95) were used to evaluate the performance of SAM, MedSAM, SAM-LoRA, and MedSAM-LoRA. Additionally, subgroup evaluations were performed according to scanner manufacturer, glioma location, and calcification status. In the external test at the case level using SAM-LoRA and MedSAM-LoRA, the Dice coefficients/IoU/HD95 were 0.9166/0.8506/1.3517 and 0.9051/0.8342/1.8061, respectively. Both SAM-LoRA and MedSAM-LoRA demonstrated significantly higher Dice coefficients and IoU, as well as significantly lower HD95 values, compared with SAM and MedSAM. Subgroup evaluations also showed highly accurate extraction across different scanner manufacturers, glioma locations, and calcification statuses. SAM-LoRA and MedSAM-LoRA achieved high accuracy on an externally evaluated dataset, suggesting potential utility.
Indexed as
Identifiers
42675269What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.